Total Payments
$4,086
2024 Payments
$473.28
Companies
36
Transactions
339
Medicare Patients
2,131
Medicare Billing
$161,053
Payment Breakdown by Category
Food & Beverage$4,086 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,086 | 339 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,247 | 154 | $0 (2024) |
| ABBVIE INC. | $570.99 | 35 | $0 (2024) |
| Lilly USA, LLC | $309.61 | 24 | $0 (2024) |
| Amgen Inc. | $227.79 | 19 | $0 (2024) |
| Novo Nordisk Inc | $216.52 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $196.97 | 13 | $0 (2022) |
| Xeris Pharmaceuticals, Inc. | $134.20 | 5 | $0 (2023) |
| PFIZER INC. | $125.94 | 6 | $0 (2024) |
| Exact Sciences Corporation | $95.81 | 4 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $85.49 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $473.28 | 40 | ABBVIE INC. ($152.37) |
| 2023 | $498.25 | 33 | GlaxoSmithKline, LLC. ($177.51) |
| 2022 | $571.29 | 58 | GlaxoSmithKline, LLC. ($212.09) |
| 2021 | $978.76 | 80 | GlaxoSmithKline, LLC. ($274.20) |
| 2020 | $355.36 | 31 | GlaxoSmithKline, LLC. ($164.99) |
| 2019 | $365.89 | 25 | Lilly USA, LLC ($108.60) |
| 2018 | $261.18 | 19 | Astellas Pharma US Inc ($55.23) |
| 2017 | $581.65 | 53 | GlaxoSmithKline, LLC. ($218.10) |
All Payment Transactions
339 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.29 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.74 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: Oncology | ||||||
| 09/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.02 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.19 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.58 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.54 | General |
| Category: RESPIRATORY | ||||||
| 07/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.92 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: RESPIRATORY | ||||||
| 07/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Obesity | ||||||
| 06/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Endocrinology | ||||||
| 06/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: VACCINES | ||||||
| 05/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.30 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.84 | General |
| Category: RESPIRATORY | ||||||
| 05/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Inflammation | ||||||
| 05/23/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 561 | 787 | $130,382 | $45,742 |
| 2022 | 5 | 506 | 771 | $120,915 | $44,589 |
| 2021 | 6 | 545 | 815 | $118,756 | $43,277 |
| 2020 | 4 | 519 | 812 | $98,577 | $27,446 |
Total Patients
2,131
Total Services
3,185
Medicare Billing
$161,053
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 218 | 389 | $61,964 | $23,705 | 38.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 122 | 127 | $32,207 | $11,090 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 117 | 164 | $19,190 | $6,927 | 36.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $8,745 | $1,683 | 19.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 12 | 12 | $3,444 | $1,427 | 41.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $3,345 | $659.45 | 19.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 16 | 16 | $448.00 | $136.00 | 30.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 12 | 12 | $609.00 | $72.72 | 11.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 16 | 19 | $431.00 | $41.80 | 9.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 196 | 391 | $60,664 | $24,153 | 39.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 141 | 142 | $34,694 | $11,902 | 34.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 142 | 210 | $24,633 | $8,427 | 34.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 13 | 13 | $624.00 | $74.26 | 11.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 14 | 15 | $300.00 | $33.30 | 11.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 194 | 319 | $49,450 | $18,839 | 38.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 166 | 303 | $35,236 | $13,632 | 38.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 124 | 126 | $30,813 | $10,277 | 33.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 20 | 23 | $1,889 | $381.08 | 20.2% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 20 | 20 | $900.00 | $107.61 | 12.0% |
| 81003 | Automated urinalysis test | Office | 2021 | 21 | 24 | $468.00 | $40.50 | 8.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 216 | 407 | $46,688 | $12,738 | 27.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 187 | 284 | $42,876 | $12,617 | 29.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 31 | 31 | $7,438 | $1,997 | 26.8% |
| 81003 | Automated urinalysis test | Office | 2020 | 85 | 90 | $1,575 | $94.04 | 6.0% |
About Dr. Thomas Neal, MD
Dr. Thomas Neal, MD is a Family Medicine healthcare provider based in Coeur D Alene, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922079235.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Neal, MD has received a total of $4,086 in payments from pharmaceutical and medical device companies, with $473.28 received in 2024. These payments were reported across 339 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($4,086).
As a Medicare-enrolled provider, Neal has provided services to 2,131 Medicare beneficiaries, totaling 3,185 services with total Medicare billing of $161,053. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Coeur D Alene, ID
- Active Since 01/27/2006
- Last Updated 03/16/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1922079235
Products in Payments
- TRELEGY ELLIPTA (Drug) $711.01
- VRAYLAR (Drug) $200.71
- QULIPTA (Drug) $186.52
- XARELTO (Drug) $179.94
- SHINGRIX (Biological) $154.95
- EMGALITY (Drug) $151.09
- BREO (Drug) $126.61
- KEVEYIS (Drug) $114.22
- NURTEC ODT (Drug) $107.44
- Aimovig (Biological) $104.50
- Cologuard Collection Kit (Device) $95.81
- PREVNAR 20 (Biological) $93.33
- ANORO ELLIPTA (Drug) $88.49
- Victoza (Drug) $88.28
- BASAGLAR (Drug) $87.08
- Otezla (Drug) $85.38
- ANORO (Drug) $81.55
- XIFAXAN (Drug) $72.25
- UBRELVY (Drug) $71.15
- SYMBICORT (Drug) $68.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Coeur D Alene
Henry Downs, Md, MD
Family Medicine — Payments: $115,400
Family Medicine $115,400
Crystal Pyrak, Md, MD
Family Medicine — Payments: $45,028
Family Medicine $45,028
Mr. Douglas Linford, Md, MD
Family Medicine — Payments: $7,746
Family Medicine $7,746
Dr. Alyssa Shaw, M.d, M.D
Family Medicine — Payments: $5,821
Family Medicine $5,821
Bryan Davidson, Md, MD
Family Medicine — Payments: $5,489
Family Medicine $5,489
Kelly Nelson, Do, DO
Family Medicine — Payments: $4,509
Family Medicine $4,509